Page last updated: 2024-08-23
paclitaxel and k 858
paclitaxel has been researched along with k 858 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Akasaka, K; Akinaga, S; Honda, S; Ichikawa, S; Iida, S; Ishida, H; Kusaka, H; Murakata, C; Nakai, R; Nitta, M; Okamoto, S; Saya, H; Takada, C; Takahashi, T; Tsujita, T; Yamashita, Y | 1 |
Other Studies
1 other study(ies) available for paclitaxel and k 858
| Article | Year |
|---|---|
K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells.
Topics: Animals; Calcium-Binding Proteins; Cell Cycle Proteins; Cell Death; Cell Nucleus; Colorectal Neoplasms; HCT116 Cells; Humans; Kinesins; Mad2 Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubules; Mitosis; Paclitaxel; Polyploidy; Repressor Proteins; Spindle Apparatus; Thiadiazoles; Xenograft Model Antitumor Assays | 2009 |